Company

ADIAL PHARMACEUTICALS, INC.

Public · ADIL

Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions and related disorders.

ADIAL PHARMACEUTICALS, INC. is a publicly traded company. It trades under the ticker ADIL. Leadership tracked by CEOInsider includes Matthew Davidson (CEO).

www.adial.com ↗LinkedIn ↗

Leadership

Current

Matthew Davidson

CEO

Recent developments

AI summary of recent coverage

Recent coverage of Adial Pharmaceuticals has focused on significant corporate changes, including announced leadership transitions tied to an upcoming annual shareholder meeting and a planned merger with Azora Therapeutics. The company has also been in the news for executive team expansion, completion of a substantial financing round, and quarterly financial results amid discussion of potential shareholder dilution related to the merger.

Summarized from the headlines in the sidebar; see each source for the full story.